Related Experiment Videos
[Thyroid papillary microcarcinoma. Salah Azaiz Institute experience]
Z Oueslati1, M Aloui, S Gritli
1Institut Salah Azaiz, Service de Chirurgie Carcinologiue Maxillo-Faciale et Oto-Rhino-Laryngologique, Tunis, Tunisie.
Abstract:
The incidence of thyroid papillary microcarcinoma appears to be increasing and therapeutic modalities remain controversial. This retrospective study concerns 25 cases, from 1978 to 1999. The circumstances of diagnosis were: a cervicotomy for thyroid nodule (88% of cases), cervical node metastases (8%), and osseous metastases (4%). The sensitivity of ultrasounds was 22.2%, that of scintigraphy was 9.1% and that of extemporaneous histological examination was 18.2%. Multifocality was found in 16% of cases and bilaterality in 16.6%. Treatment modalities were guided by histological examination. Adjunctive radioiodine ablation was used for 20% of the patients. The treatment of the osseous metastases was completed with external irradiation. The average follow up was 4.8 years (4 months to 19 years), with a rate of survival without disease of 100%.